Use of touch imprint cytology as a simple method to enrich tumor cells for molecular analysis

Cancer Cytopathology

Volumn 121, Issue 7, 2013, Pages 354-360

  Dogan, Snjezana ^a   Becker, Jillian C ^a   Rekhtman, Natasha ^a   Tang, Laura H ^a   Nafa, Khedoudja ^a   Ladanyi, Marc ^a   Klimstra, David S ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Molecular analysis; Sanger sequencing; Touch imprint cytology; Tumor enrichment; Tumor procurement

Indexed keywords

EOSIN; HEMATOXYLIN; DNA; KRAS PROTEIN, HUMAN; ONCOPROTEIN; RAS PROTEIN;

ADENOCARCINOMA; ARTICLE; CANCER CELL; COLORECTAL CARCINOMA; COMPARATIVE STUDY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CYTOLOGY; ELECTROPHORESIS; EXON; GENE MUTATION; HUMAN; HUMAN CELL; LIVER METASTASIS; MICROSCOPY; ONCOGENE K RAS; PRIORITY JOURNAL; TISSUE PREPARATION; TOUCH IMPRINT CYTOLOGY; COLORECTAL TUMOR; CYTODIAGNOSIS; GENETICS; LIVER TUMOR; LUNG TUMOR; METASTASIS; METHODOLOGY; MOLECULAR ANALYSIS; MUTATION; NUCLEOTIDE SEQUENCE; PANCREAS CARCINOMA; PATHOLOGY; SANGER SEQUENCING; TUMOR ENRICHMENT; TUMOR PROCUREMENT; UTILIZATION REVIEW;

MOLECULAR ANALYSIS; SANGER SEQUENCING; TOUCH IMPRINT CYTOLOGY; TUMOR ENRICHMENT; TUMOR PROCUREMENT;

ADENOCARCINOMA; CARCINOMA, PANCREATIC DUCTAL; COLORECTAL NEOPLASMS; CYTODIAGNOSIS; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MUTATION; PROTO-ONCOGENE PROTEINS; RAS PROTEINS;

EID: 84884755400     PISSN: None     EISSN: 19346638     Source Type: Journal    
DOI: 10.1002/cncy.21292     Document Type: Article

References (19)

1. Walch A, Komminoth P, Hutzler P, Aubele M, Hofler H, Werner M. Microdissection of tissue sections: Application to the molecular genetic characterisation of premalignant lesions. Pathobiology. 2000;68:9-17. (Pubitemid 30434162)
2. Going JJ, Lamb RF. Practical histological microdissection for PCR analysis. J Pathol. 1996;179:121-124. (Pubitemid 26182872)
3. Bonner RF, Emmert-Buck M, Cole K, et al. Laser capture microdissection: molecular analysis of tissue. Science. 1997;278:1481-1483.
4. Simone NL, Bonner RF, Gillespie JW, Emmert-Buck MR, Liotta LA. Laser-capture microdissection: opening the microscopic frontier to molecular analysis. Trends Genet. 1998;14:272-276. (Pubitemid 28341788)
5. Maitra A, Wistuba II, Virmani AK, et al. Enrichment of epithelial cell for molecular studies. Nat Med. 1999;5:459-463. (Pubitemid 29180589)
6. Scucchi LF, Di Stefano D, Cosentino L, Vecchione A. Value of cytology as an adjunctive intraoperative diagnostic method. An audit of 2, 250 consecutive cases. Acta Cytol. 1997;41:1489-1496. (Pubitemid 27391620)
7. Tew K, Irwig L, Matthews A, Crowe P, Macaskill P. Meta-analysis of sentinel node imprint cytology in breast cancer. Br J Surg. 2005;92:1068-1080. (Pubitemid 41284870)
8. Barranger E, Antoine M, Grahek D, Callard P, Uzan S. Intraoperative imprint cytology of sentinel nodes in breast cancer. J Surg Oncol. 2004;86:128-133. (Pubitemid 38720762)
9. Bukhari MH, Akhtar ZM. Comparison of accuracy of diagnostic modalities for evaluation of breast cancer with review of literature. Diagn Cytopathol. 2009;37:416-424.
10. Pan Q, Pao W, Ladanyi M. Rapid polymerase chain reaction-based detection of epidermal growth factor receptor gene mutations in lung adenocarcinomas. J Mol Diagn. 2005;7:396-403. (Pubitemid 41149655)
11. Arcila M, Lau C, Nafa K, Ladanyi M. Detection of KRAS and BRAF mutations in colorectal carcinoma roles for high-sensitivity locked nucleic acid-PCR sequencing and broad-spectrum mass spectrometry genotyping. J Mol Diagn. 2011;13:64-73.
12. Grizzle WE, Aamodt R, Clausen K, LiVolsi V, Pretlow TG, Qualman S. Providing human tissues for research: how to establish a program. Arch Pathol Lab Med. 1998;122:1065-1076. (Pubitemid 29009398)
13. Grizzle WE, Sexton KC. Development of a facility to supply human tissues to aid in medical research. In: Srivastava S, Henson DE, Gazdar A, eds. Molecular Pathology of Early Cancer. Amsterdam: IOS Press; 1999:371-383.
14. Grizzle WE, Bell W, Sexton KC. Best practices and challenges in collecting and processing human tissues to support biomedical research. AACR 96th Annual Meeting, Anaheim, CA, Education Book 2005:305-310.
15. Arcila ME, Oxnard GR, Nafa K, et al. Rebiopsy of lung cancer patients with acquired resistance to EGFR inhibitors and enhanced detection of the T790M mutation using a locked nucleic acidbased assay. Clin Cancer Res. 2011;17:1169-1180.
16. Malapelle U, Bellevicine C, Russo A, Salatiello M, Palombini L, Troncone G. KRAS testing on colo-rectal carcinoma cytological imprints. Diagn Cytopathol. 2011;39:274-277.
17. Betz BL, Roh MH, Weigelin HC, et al. The application of molecular diagnostic studies interrogating EGFR and KRAS mutations to stained cytologic smears of lung carcinoma. Am J Clin Pathol. 2011;136:564-571.
18. Viertler C, Groelz D, Gundisch S, et al. A new technology for stabilization of biomolecules in tissues for combined histological and molecular analyses. J Mol Diagn. 2012;14:458-466.
19. Mezzelani A, Alasio L, Bartoli C, et al. c-erbB2/neu gene and chromosome 17 analysis in breast cancer by FISH on archival cytological fine-needle aspirates. Br J Cancer. 1999;80:519-525. (Pubitemid 29213209)